Clinical and Radiographic Benefit of a Patient With Metastatic Non-Small Cell Lung Cancer Harboring an EGFR::ERBB4 Fusion Through Use of EGFR Tyrosine Kinase Inhibitors

被引：0
|
作者：
Guimaraes-Young, Amy [1 ]
Davies, Kurtis D. [1 ]
Trevisan, Patricia [1 ]
Nijmeh, Hala [1 ]
Haag, Mary [1 ]
Aisner, Dara L. [1 ]
Patil, Tejas [2 ]
机构：
[1] Univ Colorado, Sch Med, Dept Pathol, Aurora, CO USA
[2] Univ Colorado, Sch Med, Dept Med, Div Med Oncol, Aurora, CO 80045 USA
来源：
JCO PRECISION ONCOLOGY | 2024年 / 8卷
关键词：
KIF5B-EGFR FUSION;
D O I：
10.1200/PO-24-00526
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：6
相关论文
共 50 条
  • [1] EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast
    Xiuning Le
    Eric Nadler
    Daniel B. Costa
    John Victor Heymach
    Targeted Oncology, 2023, 18 : 807 - 817
  • [2] EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast
    Le, Xiuning
    Nadler, Eric
    Costa, Daniel B.
    Heymach, John Victor
    TARGETED ONCOLOGY, 2023, 18 (06) : 807 - 817
  • [3] Durable response to EGFR tyrosine kinase inhibitors in a patient with non-small cell lung cancer harboring an EGFR kinase domain duplication
    Hirokawa, Esuteru
    Watanabe, Satomi
    Sakai, Kazuko
    Takeda, Masayuki
    Sato, Chihiro
    Takahama, Takayuki
    Nishio, Kazuto
    Nakagawa, Kazuhiko
    THORACIC CANCER, 2021, 12 (16) : 2283 - 2287
  • [4] Integrated chemotherapy with EGFR receptor tyrosine kinase inhibitors in patients with non-small cell lung cancer harboring EGFR mutation
    Maevskaya, J.
    Laktionov, K.
    Yudin, D.
    Vladimirova, L.
    ANNALS OF ONCOLOGY, 2020, 31 : S1402 - S1402
  • [5] Impact of EGFR-Tyrosine Kinase Inhibitors for Postoperative Recurrent Non-Small Cell Lung Cancer Harboring EGFR Mutations
    Igawa, S.
    Sato, Y.
    Kusuhara, S.
    Harada, S.
    Shirasawa, M.
    Kurahayashi, S.
    Okuma, Y.
    Sugimoto, A.
    Sugita, K.
    Nakahara, Y.
    Otani, S.
    Fukui, T.
    Yokoba, M.
    Mitsufuji, H.
    Kubota, M.
    Katagiri, M.
    Sasaki, J.
    Masuda, N.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2126 - S2127
  • [6] Correction to: EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non‑Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast
    Xiuning Le
    Eric Nadler
    Daniel B. Costa
    John Victor Heymach
    Targeted Oncology, 2024, 19 : 125 - 125
  • [7] TYROSINE KINASE INHIBITORS VERSUS CHEMOTHERAPY IN PATIENTS WITH METASTATIC NON-SMALL CELL LUNG CANCER HARBORING EGFR MUTATION: VENEZUELAN EXPERIENCE
    Oblitas, George A.
    Bustamante Alvarez, Jean G.
    Fuentes, Maria B.
    Rodriguez, Juan J.
    Garcia, Cristina
    Perez, Maria A.
    Kubicec, Karen
    Nunes, Patricia
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S595 - S595
  • [8] EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast (vol 18, pg 807, 2023)
    Le, Xiuning
    Nadler, Eric
    Costa, Daniel B.
    Heymach, John Victor
    TARGETED ONCOLOGY, 2024, 19 (01) : 125 - 125
  • [9] Efficacy of EGFR Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer Patients Harboring Different Types of EGFR Mutations:A Retrospective Analysis
    刘华丽
    韩光
    彭敏
    翁一鸣
    袁静萍
    杨桂芳
    于金明
    宋启斌
    Current Medical Science, 2017, 37 (06) : 864 - 872
  • [10] Efficacy of EGFR tyrosine kinase inhibitors in non-small cell lung cancer patients harboring different types of EGFR mutations: A retrospective analysis
    Hua-li Liu
    Guang Han
    Min Peng
    Yi-ming Weng
    Jing-ping Yuan
    Gui-fang Yang
    Jin-ming Yu
    Qi-bin Song
    Current Medical Science, 2017, 37 : 864 - 872
12345